Medicure Inc. (OTCMKTS:MCUJF – Get Free Report)’s stock price passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.83 and traded as high as $0.9410. Medicure shares last traded at $0.9410, with a volume of 0 shares traded.
Medicure Price Performance
The stock has a market capitalization of $9.82 million, a price-to-earnings ratio of -3.92 and a beta of 0.99. The business has a 50-day simple moving average of $0.83 and a two-hundred day simple moving average of $0.83. The company has a quick ratio of 1.00, a current ratio of 1.44 and a debt-to-equity ratio of 0.03.
Medicure (OTCMKTS:MCUJF – Get Free Report) last announced its quarterly earnings data on Wednesday, November 19th. The company reported ($0.09) earnings per share for the quarter. Medicure had a negative net margin of 13.10% and a negative return on equity of 17.91%. The firm had revenue of $5.93 million during the quarter.
About Medicure
Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.
Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.
Read More
- Five stocks we like better than Medicure
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
